ANTXR2 and gastric cancer: On the other hand, in ovarian or gastric cancer patients, no significant association between a low CMG2 mRNA expression and patients’ survival was detectable (p = 0.13 and p = 0.18, respectively; log-rank-test, see Figure 4b,d).